Natixis’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,343
| Closed | -$31.4K | – | 1198 |
|
|
2024
Q4 | $31.4K | Buy |
+10,343
| New | +$31.4K | ﹤0.01% | 899 |
|
|
2024
Q2 | – | Sell |
-79,457
| Closed | -$391K | – | 1157 |
|
|
2024
Q1 | $391K | Buy |
+79,457
| New | +$391K | ﹤0.01% | 636 |
|
|
2023
Q3 | – | Sell |
-6,455
| Closed | -$163K | – | 1138 |
|
|
2023
Q2 | $163K | Buy |
+6,455
| New | +$163K | ﹤0.01% | 746 |
|
|
2022
Q3 | – | Sell |
-85,000
| Closed | -$1.18M | – | 1086 |
|
|
2022
Q2 | $1.18M | Buy |
+85,000
| New | +$1.18M | ﹤0.01% | 744 |
|